Vimseltinib
Drug ingredientCAS 1628606-05-2
This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.
Why supply is unknownProduction is reported production, not a complete census of factories. Import value and source-country shares describe a shared customs category, not a separate chemical measurement.
Where It Comes From
Customs basis: HS 293359 · basket
These shares come from HS customs code 293359, which covers 295 tracked chemicals in total. They estimate the category's origin mix, not this chemical specifically.
- Israel
- Bulgaria
- Japan
- Spain
- Sweden
- Canada
- Taiwan
- Finland
- Portugal
- Mexico
- Belgium
- Hungary
- Austria
- Brazil
- Ukraine
- Croatia
- Malta
- South Korea
- South Africa
- Denmark
- Czech Republic
- Malaysia
- Argentina
- Poland
- Cameroon
- Australia
- Hong Kong
- Slovakia
- Latvia
2 FDA-registered drug labelers
Why It Matters
Appears in 1 drug and cosmetic product listings (FDA).
- •Romvimza
Vendor Pricing
Prices reflect listed pack sizes. Small research packs run far above bulk rates.
17 more vendors
| Vendor | Country Supplier country. Where available, shows shipping origin. When the supplier ships from a different country than where they are registered, both are shown. Most suppliers show registration country only. | $/g | Pack | Purity |
|---|---|---|---|---|
| A2B Chem LLC | United States | $3950.00 | 100 mg | 98% |
| Molnova | China | $4482.00 | 500 mg | 99% |
| Combi-Blocks, Inc. | United States | $4850.00 | 100 mg | 95% |
| AA BLOCKS | United States | $5160.00 | 100 mg | 98% |
| Aaron Chemicals LLC | Hong Kong | $5560.00 | 50 mg | 98% |
| Angene Chemical | China → Hong Kong | $5620.00 | 50 mg | 98% |
| Cayman Europe | Estonia | $9448.60 | 50 mg | 95% |
| BLD Pharmatech Co., Limited | United States | $9790.00 | 100 mg | 98% |
| BLD Pharmatech GmbH | Germany | $9790.00 | 100 mg | 98% |
| BLD Pharmatech Ltd. | China | $9790.00 | 100 mg | 98% |
| Ambeed, Inc. | United States | $9790.00 | 100 mg | 98% |
| TargetMol Chemicals | China → United States | $9870.00 | 100 mg | 99.57% |
| MedKoo Biosciences, Inc | United States | $15000.00 | 50 mg | 98% |
| MedChemExpress MCE | Sweden | $15621.10 | 100 mg | 99.94% |
| AstaTech, Inc | United States | $19800.00 | 25 mg | 95% |
| TargetMol Chemicals US | United States | $22480.00 | 25 mg | 99.57% |
| Angene International Limited | United States | $33200.00 | 25 mg | 95% |
Chemical Identity
Data Sources
- PubChem · compound 86267612Retrieved 2026-04-07
- FDA National Drug Code directoryRetrieved 2026-04-25
- FDA National Drug Code directoryRetrieved 2026-04-07
- US Census international tradeReporting year: 2024 · Retrieved 2026-10-04
Brief citations
Vimseltinib (CAS 1628606-05-2) https://chemicalindependence.com/chemical/1628606-05-2/ PubChem: 86267612. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/86267612 FDA National Drug Code directory: CAS 1628606-05-2. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA National Drug Code directory: bulk match. Retrieved 2026-04-07. https://open.fda.gov/data/ndc/ US Census international trade: HS 293359 for CAS 1628606-05-2. Reporting year: 2024. https://usatrade.census.gov/